Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip J Clements

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
The Journal of Rheumatology|February 17, 2007
Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosisVanessa L Malcarne, Ingunn Hansdottir, Ann McKinney, et al.
Arthritis Research & Therapy|January 18, 2019
Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)Dinesh Khanna, Philip J Clements, Elizabeth R Volkmann, et al.
ACR Open Rheumatology|February 17, 2022
Disease Features and Gastrointestinal Microbial Composition in Patients with Systemic Sclerosis from Two Independent CohortsKristofer Andréasson, S Melanie Lee, Venu Lagishetty, et al.
European Medical Journal (Chelmsford, England)|January 30, 2023
Longitudinal Characterisation of the Gastrointestinal Tract Microbiome in Systemic SclerosisElizabeth R Volkmann, Anna-Maria Hoffmann-Vold, Yu-Ling Chang, et al.
Arthritis and Rheumatism|October 2, 2007
Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrumentDinesh Khanna, Ron D Hays, Grace S Park, et al.
Arthritis Care & Research|May 26, 2017
Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo-Controlled TrialsRajaie Namas, Donald P Tashkin, Daniel E Furst, et al.
Arthritis Care & Research|August 27, 2010
Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung studyKaren Au, Maureen D Mayes, Paul Maranian, et al.
The American Journal of Medicine|May 3, 2011
Adverse events during the Scleroderma Lung StudyDaniel E Furst, Chi-Hong Tseng, Philip J Clements, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 11, 2006
Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patientsJason C Cole, Dinesh Khanna, Philip J Clements, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 4, 2007
Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosisDinesh Khanna, Daniel E Furst, Weng Kee Wong, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Rheumatology|February 17, 2007
Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosisVanessa L Malcarne, Ingunn Hansdottir, Ann McKinney, et al.
Arthritis Research & Therapy|January 18, 2019
Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)Dinesh Khanna, Philip J Clements, Elizabeth R Volkmann, et al.
ACR Open Rheumatology|February 17, 2022
Disease Features and Gastrointestinal Microbial Composition in Patients with Systemic Sclerosis from Two Independent CohortsKristofer Andréasson, S Melanie Lee, Venu Lagishetty, et al.
European Medical Journal (Chelmsford, England)|January 30, 2023
Longitudinal Characterisation of the Gastrointestinal Tract Microbiome in Systemic SclerosisElizabeth R Volkmann, Anna-Maria Hoffmann-Vold, Yu-Ling Chang, et al.
Arthritis and Rheumatism|October 2, 2007
Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrumentDinesh Khanna, Ron D Hays, Grace S Park, et al.
Arthritis Care & Research|May 26, 2017
Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo-Controlled TrialsRajaie Namas, Donald P Tashkin, Daniel E Furst, et al.
Arthritis Care & Research|August 27, 2010
Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung studyKaren Au, Maureen D Mayes, Paul Maranian, et al.
The American Journal of Medicine|May 3, 2011
Adverse events during the Scleroderma Lung StudyDaniel E Furst, Chi-Hong Tseng, Philip J Clements, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 11, 2006
Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patientsJason C Cole, Dinesh Khanna, Philip J Clements, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 4, 2007
Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosisDinesh Khanna, Daniel E Furst, Weng Kee Wong, et al.
Pageof 10